Short Interest in Addus HomeCare Co. (NASDAQ:ADUS) Expands By 36.5%

Addus HomeCare Co. (NASDAQ:ADUS) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 548,700 shares, a growth of 36.5% from the September 15th total of 401,900 shares. Based on an average trading volume of 131,900 shares, the short-interest ratio is presently 4.2 days.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $130.63 on Monday. The business has a fifty day moving average price of $129.54 and a 200-day moving average price of $117.34. The company has a market capitalization of $2.36 billion, a PE ratio of 32.41, a PEG ratio of 2.33 and a beta of 1.04. Addus HomeCare has a 1-year low of $78.35 and a 1-year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. During the same quarter in the prior year, the company earned $0.94 earnings per share. Addus HomeCare’s revenue was up 10.4% on a year-over-year basis. On average, sell-side analysts anticipate that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of analyst reports. StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. KeyCorp initiated coverage on Addus HomeCare in a research note on Friday. They set an “overweight” rating and a $150.00 target price on the stock. Oppenheimer lifted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Stephens restated an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a report on Tuesday, August 6th. Finally, Macquarie reaffirmed an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Friday. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $131.38.

Insider Buying and Selling

In other news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at $429,165. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,917 shares of company stock worth $3,050,082. Corporate insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its holdings in Addus HomeCare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock worth $131,910,000 after purchasing an additional 19,027 shares during the period. Wellington Management Group LLP lifted its position in shares of Addus HomeCare by 1.2% during the 4th quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after buying an additional 9,548 shares in the last quarter. Point72 Asset Management L.P. grew its stake in shares of Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after acquiring an additional 315,602 shares during the period. Dimensional Fund Advisors LP increased its holdings in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares in the last quarter. Finally, Principal Financial Group Inc. raised its stake in Addus HomeCare by 20.9% during the 2nd quarter. Principal Financial Group Inc. now owns 430,444 shares of the company’s stock worth $49,979,000 after acquiring an additional 74,488 shares during the period. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.